eFFECTOR Therapeutics
(OTC) EFTR
eFFECTOR Therapeutics Financials at a Glance
Market Cap
$2.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$162.00K
Net Income (TTM)
-$34.63M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-15.27 (Low)
Dividend
$0.00
Beta (Volatility)
-15.27 (Low)
Price
$0.00
Volume
4
Open
$0.00
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
-15.27 (Low)
Price
$0.00
Volume
4
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Aug 12, 2026
EFTR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout eFFECTOR Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
14
CEO
Stephen T. Worland, PhD
Website
www.effector.comHeadquarters
Solana Beach, CA 92075, US
EFTR Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
3771.56%
Return on Capital
-229.45%
Return on Assets
-174.31%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
4.70M
Volume
4
Avg. Volume
1.91K
Financials (TTM)
Gross Profit
$51.00K
Operating Income
-$33.15M
EBITDA
-$31.84M
Operating Cash Flow
-$29.19M
Capital Expenditure
-$84.00K
Free Cash Flow
-$29.28M
Cash & ST Invst.
$25.38M
Total Debt
$20.25M
eFFECTOR Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$28.00K
+0.0%
Gross Margin
0.00%
N/A
Market Cap
$2.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$200.00
N/A
Employees
14
N/A
Net Income
-$8.83M
+11.8%
EBITDA
-$8.06M
+13.3%
Quarterly Fundamentals
Total Cash
$25.38M
+33.5%
Total Debt
$20.25M
-0.5%
Accounts Receivable
$17.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$179.00K
+316.3%
Short Term Debt
$20.07M
-1.2%
Return on Assets
-1.74%
N/A
Return on Invested Capital
6.44%
N/A
Free Cash Flow
-$7.28M
+4.9%
Operating Cash Flow
-$7.28M
+4.7%